BTG2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.480200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.928800E-01
Normal-vs-Stage2
9.097000E-01
Normal-vs-Stage3
8.413800E-01
Normal-vs-Stage4
5.200400E-01
Stage1-vs-Stage2
1.440800E-01
Stage1-vs-Stage3
6.454200E-01
Stage1-vs-Stage4
9.318200E-01
Stage2-vs-Stage3
6.703200E-01
Stage2-vs-Stage4
1.670980E-01
Stage3-vs-Stage4
5.571600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.132400E-01
Normal-vs-AfricanAmerican
3.764200E-01
Normal-vs-Asian
5.340600E-01
Caucasian-vs-AfricanAmerican
1.902430E-01
Caucasian-vs-Asian
3.796200E-01
AfricanAmerican-vs-Asian
1.364400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.918000E-01
Normal-vs-Female
8.461000E-01
Male-vs-Female
3.816500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.215400E-01
Normal-vs-Age(41-60Yrs)
8.103600E-01
Normal-vs-Age(61-80Yrs)
9.672400E-01
Normal-vs-Age(81-100Yrs)
6.152000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.771000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.153200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.279800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.683200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.886000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.892800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.742800E-01
Normal-vs-Daily Drinker
9.365800E-01
Normal-vs-Weekly Drinker
3.525600E-01
Normal-vs-Occasional Drinker
8.603200E-01
Normal-vs-Social Drinker
7.877800E-01
Non Drinker-vs-Daily Drinker
6.667600E-01
Non Drinker-vs-Weekly Drinker
1.972020E-01
Non Drinker-vs-Occasional Drinker
9.198800E-01
Non Drinker-vs-Social Drinker
7.132800E-01
Daily Drinker-vs-Weekly Drinker
1.894240E-01
Daily Drinker-vs-Occasional Drinker
6.609400E-01
Daily Drinker-vs-Social Drinker
5.653400E-01
Weekly Drinker-vs-Occasional Drinker
3.192000E-01
Weekly Drinker-vs-Social Drinker
5.202600E-01
Occasional Drinker-vs-Social Drinker
8.202400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.067800E-01
Normal-vs-Grade 2
4.057400E-01
Normal-vs-Grade 3
4.700200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.683800E-01
Grade 1-vs-Grade 3
7.059000E-01
Grade 1-vs-Grade 4
4.067800E-01
Grade 2-vs-Grade 3
5.086400E-01
Grade 2-vs-Grade 4
4.057400E-01
Grade 3-vs-Grade 4
4.700200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.913200E-01
Normal-vs-NonDiabetic
8.157000E-01
Diabetic-vs-NonDiabetic
7.281600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.912400E-01
Normal-vs-NoPancreatitis
7.972000E-01
Pancreatitis-vs-NoPancreatitis
8.122600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.959600E-01
Normal-vs-N1
9.103000E-01
N0-vs-N1
6.935600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.149800E-01
Normal-vs-TP53-NonMutant
9.635200E-01
TP53-Mutant-vs-TP53-NonMutant
9.964000E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
